AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site N66S
Virus Influenzavirus A H1N1
Mutation level Amino acid Level
Gene/protein/region type PB1
Gene ID 23308122
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence CY010378.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity increase
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase PB1
Uniprot protein ID C3W5X7
Protein length 757 amino acids
Protein description RNA-dependent RNA polymerase which is responsible for replication and transcription of virus RNA segments. The transcription of viral mRNAs occurs by a unique mechanism called cap-snatching. 5' methylated caps of cellular mRNAs are cleaved after 10-13 nucleotides by PA. In turn, these short capped RNAs are used as primers by PB1 for transcription of viral mRNAs. During virus replication, PB1 initiates RNA synthesis and copy vRNA into complementary RNA (cRNA) which in turn serves as a template for the production of more vRNAs

Literature information:


Pubmed ID 22318139
Clinical information No
Disease -
Published year 2012
Journal JOURNAL OF VIROLOGY
Title PB1-F2 modulates early host responses but does not affect the pathogenesis of H1N1 seasonal influenza virus
Author Isabelle Meunier,Veronika von Messling
Evidence An early delay in innate immune activation has been observed in lung tissues of mice infected with a sublethal mouse-adapted virus carrying the PB1-F2 N66S mutation (3), supporting a growing body of evidence from in vitro studies that PB1-F2 delays innate immune activation (5, 30).